The Archive · 6 posts
Innovative chemistry at its best! 🌟 Synthomer PLC (SYNT) leads the way in specialty chemicals on the LSE. Discover more today! 🔍
Synthomer FY2025: margins up to 7.8%, free cash flow positive, net debt lower. Refinancing extends to 2029. Key takeaways from the chemicals group's results.
April 30, 2026
Showing 5 of 6 posts
Synthomer confirms resilient 2025 earnings, positive cash flow & no equity raise planned. Focus now on constructive refinancing talks & asset sales to manage 2027 maturities.
JoshuaMarch 19, 2026
Synthomer's 2025 update shows resilient earnings, positive cash flow, and lower debt through margin improvement and cost savings in a tough market.
JoshuaJanuary 29, 2026
Synthomer taps major shareholder KLK for £50m receivables purchase to secure year-end covenant headroom in temporary, arms-length deal.
JoshuaDecember 18, 2025
Synthomer H1 EBITDA grows 5.4% despite revenue dip, as margin expansion and cost discipline drive strategic transformation amid market turbulence.
JoshuaAugust 5, 2025
Synthomer's Q1 2025 EBITDA growth driven by cost efficiencies & regional manufacturing strategy, resilient amid trade tensions and market uncertainty.
JoshuaMay 1, 2025
December 18, 2025